C.H.U. Poitiers
Poitiers, 86000, France
NCT Number: NCT06743347
This research will enhance our knowledge and understanding of Cerebrospinal Fluid (CSF) circulation around the Central Nervous System (CNS) (brain and spinal cord).
The main objective is to obtain flow velocities using Phase Contrast (PC) MRI over the entire subarachnoid space (SAS). This will enable us to develop and validate a numerical model of the SAS.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Poitiers, 86000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion criteria
during the study:
Pass a Phase Contrast MRI. No injection required.
Time frame: Time PC-MRI will be around 60min
Displacement velocities of CSF will be obtain by Phase Contrats MRI.
Time frame: Time PC-MRI will be around 60min
Comparison of velocity fields for each measurement section plane
Time frame: Time PC-MRI will be around 60min
Displacement velocities of blood will be obtain by Phase Contrats MRI.
Poitiers University Hospital
Other
Acronym: DYNA-LCS P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07044037
Abscess, Blood-Borne Infections
Saint-Denis, France
View Trial DetailsNCT03830762
Central Nervous System, Cerebrospinal Fluid
Perth, Western Australia, Australia
View Trial DetailsNCT00718393
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
View Trial DetailsNCT00714636
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Philadelphia, Pennsylvania, United States
View Trial Details